Table 2 RESP Score components by cohort
COVID-19 ARDS (N = 82) | Non-COVID-19 ARDS (N = 175) | Total (N = 257) | Missing, n (%) | |
|---|---|---|---|---|
Age categories (years) | 0 (0.0%) | |||
18–49 | 60 (73.2%) | 120 (68.6%) | 180 (70.0%) | |
50–59 | 18 (22.0%) | 32 (18.3%) | 50 (19.5%) | |
≥ 60 | 4 (4.9%) | 23 (13.1%) | 27 (10.5%) | |
RESP diagnoses | 0 (0.0%) | |||
Viral pneumonia | 82 (100.0%) | 70 (40.0%) | 152 (59.1%) | |
Bacterial pneumonia | 0 (0.0%) | 24 (13.7%) | 24 (9.3%) | |
Asthma | 0 (0.0%) | 1 (0.6%) | 1 (0.4%) | |
Trauma or burns | 0 (0.0%) | 6 (3.4%) | 6 (2.3%) | |
Aspiration pneumonitis | 0 (0.0%) | 38 (21.7%) | 38 (14.8%) | |
Other acute respiratory diagnosis | 0 (0.0%) | 36 (20.6%) | 36 (14.0%) | |
Non-respiratory or chronic respiratory diagnosis | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
Immunocompromised* | 1 (1.2%) | 19 (11.0%) | 20 (7.8%) | 2 (0.8%) |
NMB prior to ECMO | 80 (97.6%) | 127 (72.6%) | 207 (80.5%) | 0 (0.0%) |
Acute non-pulmonary infection | 8 (9.8%) | 21 (12.0%) | 29 (11.3%) | 0 (0.0%) |
NO before ECMO | 24 (30.0%) | 35 (20.1%) | 59 (23.2%) | 3 (1.2%) |
Bicarb infusion prior to ECMO | 6 (7.3%) | 35 (20.1%) | 41 (16.0%) | 1 (0.4%) |
Cardiac arrest prior to ECMO | 3 (3.7%) | 22 (12.6%) | 25 (9.7%) | 0 (0.0%) |
pCO2 ≥ 75 mm Hg | 37 (45.1%) | 47 (27.5%) | 84 (33.2%) | 4 (1.6%) |
Peak pressure > 42 cm H2O | 16 (19.5%) | 24 (14.0%) | 40 (15.7%) | 3 (1.2%) |
Ventilator prior to ECMO | 0 (0.0%) | |||
< 2 days | 23 (28.0%) | 85 (48.6%) | 108 (42.0%) | |
2–7 days | 33 (40.2%) | 64 (36.6%) | 97 (37.7%) | |
> 7 days | 26 (31.7%) | 26 (14.9%) | 52 (20.2%) |